{
    "Trade/Device Name(s)": [
        "BD GeneOhm\u2122 StaphSR Assay"
    ],
    "Submitter Information": "BD Diagnostics (GeneOhm Sciences Canada Inc.)",
    "510(k) Number": "K071026",
    "Predicate Device Reference 510(k) Number(s)": [
        "K851949",
        "K863821",
        "K020322",
        "K023301",
        "K042357"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQX"
    ],
    "Summary Letter Date": "December 20, 2007",
    "Summary Letter Received Date": "November 26, 2007",
    "Submission Date": "November 23, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Staphylococcus aureus",
        "Methicillin-resistant Staphylococcus aureus (MRSA)"
    ],
    "Specimen Type(s)": [
        "Positive blood culture (Gram positive cocci identified by Gram stain)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "SmartCycler"
    ],
    "Method(s)/Technology(ies)": [
        "Polymerase chain reaction (PCR)",
        "Real-time PCR",
        "Fluorogenic target-specific hybridization probe detection"
    ],
    "Methodologies": [
        "PCR amplification",
        "Molecular beacon probe detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "System",
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for BD GeneOhm StaphSR Assay, a real-time PCR assay for rapid detection of Staphylococcus aureus and MRSA from positive blood cultures",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test for rapid detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus directly from positive blood cultures using PCR and real-time probe detection; not intended to monitor treatment, and subculturing is needed for susceptibility testing.",
    "fda_folder": "Microbiology"
}